Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Relay Therapeutics
Biotech
Elevar offers $500M biobucks for Relay's rare cancer asset
Relay has signed a deal worth up to $500 million biobucks that gives Elevar rights to an oral small molecule in solid tumors.
Gabrielle Masson
Dec 3, 2024 3:04pm
Relay sheds 10% of staff after earlier layoffs in July
Oct 3, 2024 4:23pm
Relay breast cancer data tee up clash with AstraZeneca's Truqap
Sep 9, 2024 7:00am
Relay loses interest in SHP2 inhibitor after Genentech leaves
Aug 7, 2024 6:00am
Genentech sinks SHP2 pact, leaving Relay to race thinning field
Jul 17, 2024 8:01am
OnKure hitches Reneo's ride to Nasdaq, with $65M PIPE to boot
May 13, 2024 10:36am
